Internship

Summer 2025 – Computer Aided Drug Design Internship

Posted on 9/20/2024

Bristol-Myers Squibb

Bristol-Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

Biotechnology
Healthcare

Princeton, NJ, USA

Onsite presence is essential for collaboration and productivity.

Category
Bioinformatics
Computational Biology
Biology & Biotech
Required Skills
Python
Java
C/C++
Data Analysis
Requirements
  • An undergraduate student in chemistry, biological sciences, machine learning or a related field with a computational background preferred.
  • Skills in application of computational software packages in any area
  • Ability to independently analyze data using software packages.
  • Basic programming experience in at least one scripting language (e.g., Python) or programming language (Java, C, C++) preferred
  • Excellent communication and organizational skills and ability to work within a multidisciplinary teams
  • Personal attributes of curiosity, integrity, creativity, problem solving, and strong work ethic
Responsibilities
  • Computational project work that may include one or more the following - data analysis and visualization, statistical analysis, molecular modeling and software development and/or scripting.
  • Develop and build computational solutions to tackle drug discovery problems
  • Interact with project teams and collaborate on key issues for analysis and experiments
  • Communicate your analysis and findings to project teams

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and cardiovascular conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality and safety standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

Company Stage

IPO

Total Funding

$33.7B

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • BMS's AI-driven R&D enhances drug discovery and development efficiency.
  • The $3.5bn agreement with Prime Medicine boosts BMS's cell and gene-therapy pipeline.
  • BMS's commitment to ESG initiatives aligns with industry sustainability trends.

What critics are saying

  • Lawsuits against HRSA and HHS could lead to regulatory and financial challenges.
  • The $6.4 billion lawsuit by UMB poses potential financial liabilities for BMS.
  • The collaboration with AI Proteins may not yield viable therapeutic candidates.

What makes Bristol-Myers Squibb unique

  • BMS focuses on oncology, immunology, and cardiovascular diseases for innovative treatments.
  • The company invests heavily in R&D to develop new drugs and therapies.
  • BMS offers both innovative and generic medicines, increasing healthcare accessibility.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE